Inovio announces partial hold on Covid-19 vaccine candidate trial over FDA queries

This article was originally published here

The company’s investigational new drug application (IND) for the clinical trial will be on partial clinical hold until the regulator receives satisfying answers for the questions. The partial

The post Inovio announces partial hold on Covid-19 vaccine candidate trial over FDA queries appeared first on Pharmaceutical Business review.